VanEck Biotech Competition
| BBH Etf | USD 197.88 2.88 1.48% |
VanEck Biotech vs FT Cboe Correlation
Very weak diversification
The correlation between VanEck Biotech ETF and DAUG is 0.59 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Biotech ETF and DAUG in the same portfolio, assuming nothing else is changed.
Moving together with VanEck Etf
VanEck Biotech Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between VanEck Biotech and its competitors represents the degree of relationship between the price movements of corresponding etfs. A correlation of about +1.0 implies that the price of VanEck and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of VanEck Biotech ETF does not affect the price movement of the other competitor.
VanEck Biotech Constituents Risk-Adjusted Indicators
There is a big difference between VanEck Etf performing well and VanEck Biotech ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VanEck Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SMOT | 0.67 | 0.04 | (0.02) | 0.39 | 0.73 | 1.63 | 3.76 | |||
| DJD | 0.57 | 0.12 | 0.19 | 0.22 | 0.29 | 1.43 | 2.92 | |||
| FEP | 0.60 | 0.15 | 0.17 | 0.28 | 0.52 | 1.46 | 3.30 | |||
| DJAN | 0.21 | 0.01 | (0.07) | 0.09 | 0.27 | 0.53 | 2.07 | |||
| DDEC | 0.23 | 0.01 | (0.08) | 0.08 | 0.28 | 0.60 | 2.13 | |||
| QMOM | 1.10 | (0.03) | (0.02) | 0.03 | 1.73 | 1.84 | 6.14 | |||
| GVUS | 0.52 | 0.09 | 0.12 | 0.16 | 0.44 | 1.32 | 3.01 | |||
| FAD | 0.92 | (0.05) | (0.03) | 0.01 | 1.23 | 1.61 | 4.94 | |||
| BLUX | 0.65 | 0.05 | 0.00 | 0.43 | 0.80 | 1.54 | 3.57 | |||
| DAUG | 0.22 | 0.00 | (0.12) | 0.04 | 0.30 | 0.46 | 1.70 |
VanEck Biotech Competitive Analysis
The better you understand VanEck Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, VanEck Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across VanEck Biotech's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
VanEck Biotech Competition Performance Charts
Five steps to successful analysis of VanEck Biotech Competition
VanEck Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by VanEck Biotech ETF in relation to its competition. VanEck Biotech's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of VanEck Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact VanEck Biotech's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to VanEck Biotech ETF, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your VanEck Biotech position
In addition to having VanEck Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banks Thematic Idea Now
Banks
Large and small money and credit banks and credit services. The Banks theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out VanEck Biotech Correlation with its peers. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
VanEck Biotech ETF's market price often diverges from its book value, the accounting figure shown on VanEck's balance sheet. Smart investors calculate VanEck Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since VanEck Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between VanEck Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding VanEck Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.